# A Randomized, Double-Blind, Parallel, Non-Inferiority, Multicenter Trial Evaluate the Efficacy and Safety of UNCNT Compared to MELSMON in Female With Menopausal Syndrome

> **NCT01931748** · PHASE3 · COMPLETED · sponsor: **Unimed Pharmaceuticals** · enrollment: 104 (actual)

## Conditions studied

- Menopausal Syndrome

## Interventions

- **DRUG:** MELSMON
- **DRUG:** UNCNT

## Key facts

- **NCT ID:** NCT01931748
- **Lead sponsor:** Unimed Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2014-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01931748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01931748, "A Randomized, Double-Blind, Parallel, Non-Inferiority, Multicenter Trial Evaluate the Efficacy and Safety of UNCNT Compared to MELSMON in Female With Menopausal Syndrome". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01931748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*